参考文献/References:
[1] Reshetnyak VI.Physiological and molecular biochemical mecha-nisms of bile formation[J].World J Gastroenterol,2013,19（42）：7341-7360.
[2] Dias V,Ribeiro V.Ethnic differences in the prevalence of poly-morphisms in CYP7A1,CYP7B1 AND CYP27A1 enzymes involved in cholesterol metabolism[J].J Pharm Bioallied Sci,2011,3（3）：453-459.
[3] Chiang JY.Bile acid metabolism and signaling[J].Compr Physiol,2013,3（3）：1191-1212.
[4] Smushkin G,Sathananthan M,Piccinini F,et al.The effect of a bile acid sequestrant on glucose metabolism in subjects with type 2 diabetes[J].Diabetes,2013,62（4）：1094-1101.
[5] Hebanowska A.Mechanisms of bile acid biosynthesis regulation--autoregulation by bile acids[J].Postepy Biochem,2011,57（3）：314-323.
[6] Brufau G,Bahr MJ,Staels B,et al.Plasma bile acids are not associated with energy metabolism in humans[J].Nutr Metab （Lond）, 2010,7：73.
[7] Suhre K,Meisinger C,D?觟ring A,et al.Metabolic footprint of diabetes：a multiplatform metabolomics study in an epidemio-logical setting[J].PLoS One,2010,5（11）：e13953.
[8] Herrema H,Meissner M,van Dijk TH,et al.Bile salt sequestration induces hepatic de novo lipogenesis through farnesoid X receptor-and liver X receptor alpha-controlled metabolic pathways in mice[J].Hepatology,2010,51（3）：806-816.
[9] Kohli R,Kirby M,Setchell KD,et al.Intestinal adaptation after ileal interposition surgery increases bile acid recycling and protects against obesity-related comorbidities[J].Am J Physiol Gastrointest Liver Physiol,2010,299（3）：G652-G660.
[10] Pournaras DJ,Glicksman C,Vincent RP,et al.The role of bile after Roux-en-Y gastric bypass in promoting weight loss and improving glycaemic control[J].Endocrinology,2012,153（8）：3613-3619.
[11] Prawitt J,Staels B.Bile acid sequestrants：glucose-lowering mechanisms[J].Metab Syndr Relat Disord,2010,8（Suppl 1）：S3-S8.
[12] Ooi CP,Loke SC.Colesevelam for Type 2 diabetes mellitus：an abridged Cochrane review[J].Diabet Med,2014,31（1）：2-14.
[13] Düfer M,H?觟rth K,Krippeit-Drews P,et al.The significance of the nuclear farnesoid X receptor （FXR） in β cell function[J].Islets,2012,4（5）：333-338.
[14] Miao J,Choi SE,Seok SM,et al.Ligand-dependent regulation of the activity of the orphan nuclear receptor, small heterodimer partner（SHP）,in the repression of bile acid biosynthetic CYP7A1 and CYP8B1 genes[J].Mol Endocrinol,2011,25（7）：1159-1169.
[15] Kemper JK.Regulation of FXR transcriptional activity in health and disease：Emerging roles of FXR cofactors and post-translational modifications[J].Biochim Biophys Acta,2011,1812（8）：842-850.
[16] Matsubara T,Li F,Gonzalez FJ.FXR signaling in the enterohepatic system[J].Mol Cell Endocrinol,2013,368（1-2）：17-29.
[17] Heni M,Wagner R,Ketterer C,et al.Genetic variation in NR1H4 encoding the bile acid receptor FXR determines fasting glucose and free fatty acid levels in humans[J].J Clin Endocrinol Metab, 2013,98（7）：E1224-E1229.
[18] Nguyen A,Bouscarel B.Bile acids and signal transduction：role in glucose homeostasis[J].Cell Signal,2008,20（12）：2180-2197.
[19] Düfer M,H?觟rth K,Wagner R,et al.Bile acids acutely stimulate insulin secretion of mouse β-cells via farnesoid X receptor acti-vation and K（ATP） channel inhibition[J].Diabetes,2012,61（6）：1479-1489.
[20] Pols TW,Noriega LG,Nomura M,et al.The bile acid membrane receptor TGR5：a valuable metabolic target[J].Dig Dis,2011,29(1)：37-44.
[21] Svensson PA,Olsson M,Andersson-Assarsson JC,et al.The TGR5 gene is expressed in human subcutaneous adipose tissue and is associated with obesity,weight loss and resting metabolic rate[J].Biochem Biophys Res Commun,2013,433（4）：563-566.
[22] Kim EK,Choi EJ.Pathological roles of MAPK signaling path-ways in human diseases[J].Biochim Biophys Acta,2010,1802（4）：396-405.
相似文献/References:
[1]曾静波,王姮.2型糖尿病与自身免疫反应[J].国际内分泌代谢杂志,2007,(04):259.
[2]朱素君,谢锦桃,刘军,等.二甲双胍：2型糖尿病治疗的基础药[J].国际内分泌代谢杂志,2007,(04):280.
[3]刘艳清 易秋艳 邵加庆.肠道菌群与肥胖和糖尿病的关系[J].国际内分泌代谢杂志,2015,(01):31.[doi:DOI：10.3760/cma.j.issn.1673-4157.2015.01.007]
Liu Yanqing,Yi Qiuyan,Shao Jiaqing..Relationship between gut microbiota, obesity and diabetes[J].International Journal of Endocrinology and Metabolism,2015,(03):31.[doi:DOI：10.3760/cma.j.issn.1673-4157.2015.01.007]
[4]姚旻 赵爱源 张宏.肠道菌群与2型糖尿病[J].国际内分泌代谢杂志,2015,(01):35.[doi:DOI：10.3760/cma.j.issn.1673-4157.2015.01.008]
Yao Min*,Zhao Aiyuan,Zhang Hong..Relationship between gut microbiota and type 2 diabetes[J].International Journal of Endocrinology and Metabolism,2015,(03):35.[doi:DOI：10.3760/cma.j.issn.1673-4157.2015.01.008]
[5]赵丽娟,徐宽枫,杨涛,等.SLC30A8和PTPRD基因多态性与南京地区中老年人群2型糖尿病的相关性研究[J].国际内分泌代谢杂志,2015,(03):145.[doi:10.3760/cma.j.issn.1673-4157.2015.03.001]
Zhao Lijuan*,Xu Kuanfeng,Yang Tao,et al.Relationship between SLC30A8 and PTPRD gene polymorphisms and type 2 diabetes in middle aged and elderly people in Nanjing area[J].International Journal of Endocrinology and Metabolism,2015,(03):145.[doi:10.3760/cma.j.issn.1673-4157.2015.03.001]
[6]王洁,何媛,于珮.糖尿病肾病的相关危险因素分析[J].国际内分泌代谢杂志,2015,(03):153.[doi:10.3760/cma.j.issn.1673-4157.2015.03.003]
Wang Jie*,He Yuan,Yu Pei..Risk factors of diabetic nephropathy[J].International Journal of Endocrinology and Metabolism,2015,(03):153.[doi:10.3760/cma.j.issn.1673-4157.2015.03.003]
[7]刘帅,张萍,方毅,等.2型糖尿病合并无症状冠状动脉钙化的相关危险因素分析[J].国际内分泌代谢杂志,2015,(03):158.[doi:10.3760/cma.j.issn.1673-4157.2015.03.004]
Liu Shuai*,Zhang Ping,Fang Yi,et al.Analysis of the risk factors related with asymptomatic coronary calcification for type 2 diabetic patients[J].International Journal of Endocrinology and Metabolism,2015,(03):158.[doi:10.3760/cma.j.issn.1673-4157.2015.03.004]
[8]徐庆海,马颖,李铁马.2型糖尿病患者高甘油三酯血症-腰围表型与甲状腺功能异常的关系[J].国际内分泌代谢杂志,2015,(04):222.[doi:10.3760/cma.j.issn.1673-4157.2015.04.002]
Xu Qinghai,Ma Ying,Li Tiema..Association of hypertriglyceridaemic-waist phenotype with thyroid dysfunction in patients with type 2 diabetes mellitus[J].International Journal of Endocrinology and Metabolism,2015,(03):222.[doi:10.3760/cma.j.issn.1673-4157.2015.04.002]
[9]潘道延,沈洁,朱筱,等.利格列汀对2型糖尿病大鼠代谢性内毒素血症的影响[J].国际内分泌代谢杂志,2015,(04):230.[doi:10.3760/cma.j.issn.1673-4157.2015.04.004]
Pan Daoyan,Shen Jie,Zhu Xiao,et al.Effects of linagliptin on metabolic endotoxemia in type 2 diabetic rats[J].International Journal of Endocrinology and Metabolism,2015,(03):230.[doi:10.3760/cma.j.issn.1673-4157.2015.04.004]
[10]黄桥,白洁,杜洪泉.一种新的脂肪细胞因子——cartonectin[J].国际内分泌代谢杂志,2015,(04):265.[doi:10.3760/cma.j.issn.1673-4157.2015.04.014]
Huang Qiao*,Bai Jie,Du Hongquan..A novel adipokine--cartonectin[J].International Journal of Endocrinology and Metabolism,2015,(03):265.[doi:10.3760/cma.j.issn.1673-4157.2015.04.014]